News Search Results
Oct 01, 2025, 09:05 ET SafeTraces Selected as a Prime Performer for ARPA-H Building Resilient Environments for Air and Total Health (BREATHE) Program on Other Transaction Agreement up to $39 Million
instead of amplifying risk." About SafeTraces, Inc.SafeTraces, Inc. is a market-leading biotechnology company focused on pathogen-proofing indoor environments. Developed with NIH, NSF, and DoD support, SafeTraces' integrated platform predicts, detects,
More news about: SafeTraces, Inc.
Oct 01, 2025, 09:01 ET Revance Expands Leadership Team with Key Executive Appointments
with strong legal, ethical, and operational foundations. Schwartz brings over 20 years of legal and executive leadership in the pharmaceutical and biotechnology sectors, most recently serving as Executive Vice President, General Counsel, and Corporate Secretary at Odyssey Therapeutics. She previously held
More news about: Revance
Oct 01, 2025, 09:00 ET SHASQI STRENGTHENS BOARD OF DIRECTORS WITH THE APPOINTMENT OF FORMER CHIEF DEVELOPMENT OFFICER AT PFIZER ONCOLOGY
About Shasqi Shasqi, Inc. is a preclinical biotechnology company whose focus is to make cancer drugs more effective with pre-targeting enabled by click chemistry, a 2022 Nobel Prize-winning innovation.
More news about: Shasqi, Inc.
Oct 01, 2025, 08:35 ET skinbetter science® Launches Mystro Revive Renewing Serum for Perimenopausal and Menopausal Skin
vitality during hormonal fluctuations associated with perimenopause and menopause. Mystro Revive Renewing Serum is formulated with P.A.T.H.[13] biotechnology and clinically tested for women in perimenopause and menopause to improve the visible signs of aging and dryness associated with this skin stage.
More news about: skinbetter science
Oct 01, 2025, 08:30 ET Identifying and mitigating risks in pediatric protocol development: Strategies, tools & access planning, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Oct 01, 2025, 08:30 ET OECD Test Guideline Updates 2025: The Impact Upon DART Study Designs and the Future Landscape of Omics, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Oct 01, 2025, 08:30 ET Accelerating Compliance Through Data Digitalization and AI, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Oct 01, 2025, 08:30 ET Atossa Therapeutics Names Janet R. Rea, MSPH, as Senior Vice President, R&D to Accelerate (Z)-Endoxifen Toward Key Regulatory Milestones
Rea most recently served as a consultant to a variety of biopharmaceutical companies. She has held senior development leadership roles for AVM Biotechnology (COO, SVP), Atossa Therapeutics, TPI Therapeutics, and Protein Sciences (now Glaxo), where she played a key role leading to the approval of FluBlok®,
More news about: Atossa Therapeutics Inc
Oct 01, 2025, 08:00 ET Monod Bio Announces Appointment of Timothy I. Still as Executive Chairman
to our stakeholders." About Monod Bio Monod Bio is a Seattle-based biotechnology company and a spinout from the David Baker Lab at the University of Washington's Institute for Protein Design. The company uses AI-powered de
More news about: Monod Bio
Oct 01, 2025, 08:00 ET RheumaGen Announces Oral Presentation on HLA Gene-Editing Preclinical Data for Lead Autoimmune Disease Program at ACR Convergence 2025
online. About RheumaGen, Inc.RheumaGen is a private biotechnology company engineering a new class of therapeutics to cure common autoimmune diseases. RheumaGen focuses on editing the human leukocyte antigen (HLA),
More news about: RheumaGen, Inc.
Oct 01, 2025, 07:30 ET Biocon Biologics Secures U.S. Market Entry Date for Bosaya™ and Aukelso™, Denosumab Biosimilars
international interest rates, change in laws and regulations that apply to the Indian and global biotechnology and pharmaceuticals industries, increasing competition in and the conditions of the Indian and global biotechnology and pharmaceuticals industries, changes in political conditions in India and changes in
More news about: Biocon Biologics
Oct 01, 2025, 07:00 ET Halozyme to Acquire Elektrofi, Expanding Our Offerings in Innovative Drug Delivery and Strengthening Long-Term Growth into 2040s
at least one major region and across more than 100 global markets, Halozyme has licensed its ENHANZE® technology to leading pharmaceutical and biotechnology companies including Roche, Takeda, Pfizer, Janssen, AbbVie, Eli Lilly, Bristol-Myers Squibb, argenx, ViiV Healthcare, Chugai Pharmaceutical and
More news about: Halozyme Therapeutics, Inc.
Oct 01, 2025, 06:30 ET Food Enzymes Market worth $4.20 billion by 2030- Exclusive Report by MarketsandMarkets™
texture, shelf life, and digestibility. This surge in demand is being further fueled by advancements in biotechnology,
More news about: MarketsandMarkets
Oct 01, 2025, 06:30 ET Immunic to Participate in Scientific and Investor Conferences in October
Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today
More news about: Immunic, Inc.
Oct 01, 2025, 06:00 ET PhotonPharma Inc. CEO to Present Novel Autologous Treatment Platform at Premier Cancer Immunotherapy Conference
The 2nd Annual Personalized Cancer Vaccine Summit brings together 80+ senior executives from leading pharmaceutical and biotechnology companies to address critical challenges in personalized cancer vaccine development. The event features presentations from industry leaders including
More news about: PhotonPharma Inc.
Oct 01, 2025, 03:00 ET MD Logistics Makes Largest Indiana Business Location Fully cGMP-compliant
*cGMP (Current Good Manufacturing Practice): regulatory standards for the manufacture and quality control of pharmaceutical and biotechnology products in the United States NX Group official website: https://www.nipponexpress.com/ NX
More news about: NIPPON EXPRESS HOLDINGS, INC.
Sep 30, 2025, 17:31 ET HPV-Positive Oropharyngeal Cancer Market Poised for Strong Growth by 2034, Driven by Rising Incidence and Treatment Innovation | DelveInsight
clinician awareness. The anticipated launch of emerging therapies such as Merck Sharp & Dohme (KEYTRUDA), Bristol Myers Squibb (OPDIVO), PDS Biotechnology (Versamune HPV/PDS0101), Inovio Pharmaceuticals and MedImmune (INO-3112/MEDI0457), Cue Biopharma (CUE-101), and others will further propel the market.
More news about: DelveInsight Business Research, LLP
Sep 30, 2025, 16:30 ET ESSA Pharma Inc. Provides Update on its Application to the Supreme Court of British Columbia for Amended Interim Order
today announced that, in connection with its previously announced Business Combination Agreement with XenoTherapeutics Inc. ("Xeno"), a non-profit biotechnology company, under which Xeno will acquire all of the issued and outstanding common shares of ESSA (the "Transaction"), ESSA received an amended Interim
More news about: ESSA Pharma Inc.
Sep 30, 2025, 13:15 ET Plug and Play and Indiana University Unveil IU LAB Lifetech Accelerator
support top-tier startups from around the globe. The program will focus on critical areas such as therapeutics, medical devices, diagnostics, and biotechnology, leveraging the deep expertise of Indiana's academic and corporate partners. Indiana University President Pam Whitten emphasized
More news about: Plug and Play
Sep 30, 2025, 12:44 ET WallachBeth Capital Announces Closing of bioAffinity Technologies Public Offering for $4.8m
provider of capital markets and institutional execution services, announced today that bioAffinity Technologies, Inc. (NASDAQ: BIAF and BIAFW) a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer has closed its previously announced public offering of
More news about: WallachBeth Capital LLC
Sep 30, 2025, 11:45 ET Made Scientific and Syenex Forge Technology Partnership to Transform T Cell Therapy Manufacturing
resources of GC Corporation of South Korea, a global leader in the pharmaceutical and biotechnology sectors. About SyenexSyenex is an open-science biotechnology platform company that enables developers to program cells with precision and scale.
More news about: Made Scientific, Inc.
Sep 30, 2025, 11:30 ET Public Cloud Market is Projected to Reach US$2312.60 Million by 2031; with CAGR of 17.7% | The Insight Partners
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials.
More news about: The Insight Partners
Sep 30, 2025, 11:15 ET Highly Directional Antenna Market is Expected to Reach US$479.92 Million by 2031 at a CAGR of 7.9% | The Insight Partners
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media, and telecommunications, as well as chemicals and materials.
More news about: The Insight Partners
Sep 30, 2025, 11:09 ET Water Cooled Chillers Market is Projected to Reach US$2.69 Billion by 2031, at a CAGR of 6.0% | The Insight Partners
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media, and telecommunications, as well as chemicals and materials.
More news about: The Insight Partners
Sep 30, 2025, 11:01 ET Omni-Directional Antenna Market Is Expected To Reach US$713.21 Million By 2031 at a CAGR Of 4.7% | The Insight Partners
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media, and telecommunications, as well as chemicals and materials.
More news about: The Insight Partners